Independent US Healthcare Provider Directory & Public Medical Database Patient Guides

Dr. Sagar Solanki , PharmD

Pharmacist β€’ Irvine, CA

Active NPI 1023630944 Individual Practitioner Male Practitioner
Practice location in NPPES

3875 Alton Pkwy
Irvine, CA 926068203

Call 9492504465 Location details and other listings
Medical Disclaimer

This profile restates public CMS/NPPES data; T-MedInfo gives no medical advice — consult a licensed professional, and call 911 for emergencies.

Practice Location & Contact Primary Location

Practice Address

3875 Alton Pkwy

Irvine, CA 926068203

Telephone 9492504465
Organization at the Same NPPES Address or Phone
Thrifty Payless Inc Facility NPI 1659480010

Matched by practice address or phone in NPPES. A shared address or phone does not confirm that this clinician works there.

30-day fills

1,980 standardized 30-day fills in 2024

CMS converts prescriptions to 30-day supplies so they can be compared. A 90-day prescription counts as about three 30-day fills.

What this does not show: 30-day fills

It is not a count of patients and not a measure of quality.

Part D drug cost

$189,722 in 2024

The total cost of these prescriptions in 2024, paid by Medicare drug plans, patients and other payers together.

What this does not show: Part D drug cost

A higher cost often reflects the type of medicines a specialty uses. It is not your out-of-pocket cost and not a measure of quality.

Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024.

NPI first issued

2020

The year this clinician's National Provider Identifier (NPI) was issued. An NPI is a unique 10-digit ID that US health care providers use for billing.

What this does not show: NPI first issued

NPIs have been issued only since 2005, so this year is not necessarily when the clinician started practicing.

Source: CMS NPPES NPI Registry.

Medicare assignment not listed

CMS data do not show whether this clinician accepts Medicare assignment. This does not mean they do not accept Medicare. Ask the office.

Medicare assignment applies to Original Medicare. It does not tell you whether the clinician is in a Medicare Advantage plan's network, accepts other insurance, or is taking new patients.

Source: CMS Doctors and Clinicians, CMS release of October 2, 2026; Medicare.gov, β€œDoes your provider accept Medicare as full payment?”

Guide: What Medicare assignment means

No telehealth indicator

CMS shows this indicator only when recent Medicare claims include telehealth services. The clinician may still offer telehealth; ask the office.

Source: CMS, Telehealth Indicator on Medicare Care Compare (fact sheet, January 2023); CMS Doctors and Clinicians, CMS release of October 2, 2026.

Guide: How Medicare covers telehealth

Compared with the same specialty in Irvine and California

Billing and prescribing volume is not a quality rating.

Medicare Part D prescriptions

More Part D prescriptions than 95% of clinicians listed under Pharmacist in Irvine, CA (2024, 31 clinicians with data). Median for this group: 65. Middle half: 35 to 91.

More Part D prescriptions than 90% of clinicians listed under Pharmacist in California (2024, 4,003 clinicians with data). Median for this group: 64. Middle half: 32 to 128.

Part D drug cost

A higher Part D drug cost than 95% of clinicians listed under Pharmacist in Irvine, CA (2024, 31 clinicians with data). Median for this group: $14,575. Middle half: $7,957 to $18,677.

A higher Part D drug cost than 90% of clinicians listed under Pharmacist in California (2024, 4,003 clinicians with data). Median for this group: $13,313. Middle half: $6,221 to $25,067.

289 active clinicians are listed under Pharmacist with a practice address in Irvine, CA (33,053 in California).

Addresses are self-reported to NPPES and may be out of date.

Telehealth indicator in Irvine

0% of these 289 clinicians have the CMS telehealth indicator.

0% of these 289 clinicians are listed by CMS as accepting Medicare assignment.

Sources: CMS Medicare Part D Prescribers (2024), CMS Doctors and Clinicians, CMS release of October 2, 2026, CMS NPPES NPI Registry. Specialty names follow the NUCC Health Care Provider Taxonomy.

Text: T-MedInfo Β· Report an error.

Medicare Part D Prescribing Profile & Medications

Medicare Part D prescriptions filled, including refills, in 2024.

CMS Part D Β· Data Year 2024
Prescription Year:
Brand Name Generic Name Prescriptions Day Supply Total Cost Patients
Ozempic Semaglutide 144 4,270 $106,545.71 24
Metformin Hcl Er Metformin Hcl 76 7,130 $714.71 34
Atorvastatin Calcium Atorvastatin Calcium 73 7,250 $830.71 32
Jardiance Empagliflozin 72 6,790 $41,367.21 28
Metformin Hcl Metformin Hcl 56 5,520 $690.15 25
Glipizide Glipizide 50 4,685 $953.79 25
Humulin N Insulin Nph Human Isophane 35 3,099 $6,946.64 16
Insulin Glargine-Yfgn Insulin Glargine-Yfgn 29 2,621 $5,609.77 14
Losartan Potassium Losartan Potassium 27 2,680 $342.63 11
Humulin N Kwikpen Insulin Nph Human Isophane 27 2,002 $4,211.53 11
Humulin R Insulin Regular, Human 25 1,815 $2,878.12 β€”
Simvastatin Simvastatin 21 2,100 $245.07 11
Lisinopril Lisinopril 20 1,830 $222.55 β€”
Lisinopril-Hydrochlorothiazide Lisinopril/Hydrochlorothiazide 14 1,280 $176.97 β€”
Ultra-Fine Mini Pen Needle Pen Needle, Diabetic 14 1,400 $434.65 β€”
Amlodipine Besylate Amlodipine Besylate 13 1,300 $141.72 β€”
Glipizide Er Glipizide 13 1,300 $334.52 β€”
Veo Insulin Syringe Syringe And Needle,insulin,1ml 12 635 $203.02 β€”
Victoza 3-Pak Liraglutide 11 330 $8,346.25 β€”
Veo Insulin Syringe Syrge-Ndl,ins 0.3 Ml Half Mark 11 710 $444.34 β€”
Liraglutide Liraglutide 11 360 $8,081.48 β€”

Source: CMS Part D by Provider and Drug, 2024; rows below 11 claims omitted by CMS; volume isn’t quality. Privacy limits

Specialties & License Numbers Reported to NPPES

Self-certified to NPPES: 2021-12-29
Pharmacist Primary Specialty

NUCC Taxonomy Code: 183500000X

License # reported to NPPES CA 82062

An individual licensed by the appropriate state regulatory agency to engage in the practice of pharmacy. The practice of pharmacy includes, but is not limited to, assessment, interpretation, evaluation, and implementation, initiation, monitoring or modification of medication and or medical orders; the compounding or dispensing of medication and or medical orders; participation in drug and device procurement, storage, and selection; drug administration; drug regimen reviews; drug or drug-related research; provision of patient education and the provision of those acts or services necessary to provide medication therapy management services in all areas of patient care.

Check License Status with the State Board License numbers are self-reported to NPPES; T-MedInfo does not confirm them against state records. Current status: Medical Board of California.
Look Up on State Board Site

Clinicians Sharing This Practice Address or Phone

Clinicians sharing this NPPES address, phone or fax; a shared contact does not mean they work together.

3 listed
NPI 1497092753

Doctor of Pharmacy (Pharm.D.)

NPI 1477865632

Doctor of Philosophy (Ph.D.)

Sylvie Nguyen

Pharmacist

NPI 1972821015

Career & Practice History Timeline

Changes recorded in monthly NPPES data files: addresses, names, credentials, specialties and NPI status

7 Historical Events
πŸ“
Updated Business Mailing Address December 29, 2021

Registered at 3875 ALTON PKWY, IRVINE, CA 926068203 (Tel: 3109382094)

βœ…
NPI Profile Active May 13, 2020

NPI status registered as active in NPPES database

πŸ“
Practice Location (Initial Record) May 13, 2020

Registered at 3875 ALTON PKWY, IRVINE, CA 926068203 (Tel: 9492504465)

πŸ“
Business Mailing Address (Initial Record) May 13, 2020

Registered at 1204 CAMPANIS LN, PLACENTIA, CA 928708228 (Tel: 3109382094)

πŸ‘€
Provider Name / Credentials (Initial Record) May 13, 2020

Recorded as SAGAR SOLANKI, PHARMD

πŸŽ“
Medical Taxonomy / Specialty Registered (Primary Specialty) May 13, 2020

Pharmacist (license number reported to NPPES: CA 82062)

🟒
Initial NPI Registration & Enumeration May 13, 2020

First registered as active Individual Practitioner in NPPES Database.

No reviews have been published yet. Leave a review.